This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cuisset, T. Articles by Alessi, M.-C. Search for Related Content PubMed PubMed Citation Articles by Cuisset, T. Articles by Alessi, M.-C.

Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting

Thomas Cuisset, MD^_*, Corinne Frere, MD, Jacques Quilici, MD^_*, Pierre-Emmanuel Morange, MD, PhD, Lyassine Nait-Saidi, MD^_*, Joseph Carvajal, MD, Agnès Lehmann, Marc Lambert, MD^_*, Jean-Louis Bonnet, MD^_* and Marie-Christine Alessi, MD, PhD^,_*

^_* Department of Cardiology, CHU Timone, Marseille, France
INSERM, Faculté de Médecine CHU Timone, Marseille, France

View larger version (16K): [in a new window]   Figure 1 Maximal intensity of adenosine diphosphate (ADP)-induced platelet aggregation in the 300-mg and 600-mg groups.

View larger version (14K): [in a new window]   Figure 2 Mean fluorescence intensity of P-selectin expression in the 300-mg and 600-mg groups. AU = arbitrary units.

View larger version (8K): [in a new window]   Figure 3 Clinical outcomes according to loading dose of clopidogrel. ACS = acute coronary syndrome; CV death = cardiovascular death; CVE = cardiovascular events; ST = stent thrombosis.

View larger version (7K): [in a new window]   Figure 4 Kaplan-Meier analysis for 30-day cardiovascular (CV) events according to loading dose of clopidogrel. Log-rank = 9.24, p < 0.0024.